134 related articles for article (PubMed ID: 6404149)
21. Metoprolol in angina pectoris complicated by essential hypertension. A clinical comparison of the antianginal efficacy of metoprolol slow-release tablets (Durules) given once daily and propranolol tablets given twice daily.
BLoem TJ; Lindner PC
Ann Clin Res; 1981; 13 Suppl 30():61-7. PubMed ID: 6794420
[TBL] [Abstract][Full Text] [Related]
22. [Beta-blockader, pindolol, in the therapy of angina pectoris; a report on a multicentric controlled study].
Lang E; Fitscha P; Schiess W
Wien Med Wochenschr; 1979 Sep; 129(17):484-8. PubMed ID: 120078
[TBL] [Abstract][Full Text] [Related]
23. [Clinical usefulness of high-dose oral nitroglycerin in patients with stable angina pectoris].
Kośmicki MA; Skorykow-Sapińska A; Sadowski Z
Wiad Lek; 2003; 56(7-8):313-8. PubMed ID: 14969156
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia.
Cocco G; Strozzi C; Chu D; Amrein R; Castagnoli E
Eur J Cardiol; 1979 Jul; 10(1):59-69. PubMed ID: 111940
[TBL] [Abstract][Full Text] [Related]
25. Antianginal effects of atenolol and pindolol in patients with stable effort angina pectoris.
Antalóczy Z; Kekes E
Zhongguo Yao Li Xue Bao; 1989 May; 10(3):222-6. PubMed ID: 2609991
[TBL] [Abstract][Full Text] [Related]
26. Studies with a slow-release formulation of propranolol in angina.
McIlmoyle EL; Blair AL; Calvert HW; Boyle DM; Shanks RG; Leahey W; Barber JM
Ir Med J; 1979 Jan; 72(1):27-8. PubMed ID: 365833
[No Abstract] [Full Text] [Related]
27. The treatment of angina pectoris with the new beta-receptor blocker carteolol. Results of a controlled trial in comparison with pindolol.
Simon H; Schuppan U
Arzneimittelforschung; 1983; 33(2a):318-21. PubMed ID: 6340700
[TBL] [Abstract][Full Text] [Related]
28. Effect of oral sustained-release nitroglycerin on exercise capacity in angina pectoris: dose-response relation and duration of action during double-blind crossover randomized acute therapy.
Degré SG; Strappart GM; Sobolski JC; Berkenboom GM; Stoupel EE; Vandermoten PP
Am J Cardiol; 1983 Jun; 51(10):1595-8. PubMed ID: 6407293
[TBL] [Abstract][Full Text] [Related]
29. Slow release nifedipine plus atenolol in chronic stable angina pectoris.
Challenor VF; Waller DG; Renwick AG; George CF
Br J Clin Pharmacol; 1989 Nov; 28(5):509-16. PubMed ID: 2511911
[TBL] [Abstract][Full Text] [Related]
30. Comparative efficacy and concomitant use of bepridil and beta blockers in the management of angina pectoris.
Frishman WH
Am J Cardiol; 1992 Apr; 69(11):50D-55D. PubMed ID: 1553892
[TBL] [Abstract][Full Text] [Related]
31. Long-term effectiveness of verapamil in stable and unstable angina pectoris. One-year follow-up of patients treated in placebo-controlled double-blind randomized clinical trials.
Scheidt S; Frishman WH; Packer M; Mehta J; Parodi O; Subramanian VB
Am J Cardiol; 1982 Nov; 50(5):1185-90. PubMed ID: 6814226
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a sustained-release buccal nitroglycerin preparation in stable angina pectoris.
Grasso S; Pesciatini F; Ugolini C; Lepore R; Cerri B
Int J Clin Pharmacol Res; 1988; 8(2):131-7. PubMed ID: 3132428
[TBL] [Abstract][Full Text] [Related]
33. Acute and chronic efficacy of low-dose nitroglycerin patches in stable angina pectoris.
Rezaković DE; Lakatos S; Stalec J; Pavicić L
Z Kardiol; 1986; 75 Suppl 3():90-5. PubMed ID: 3099489
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the effectiveness of slow-release propranolol (Inderal LA) 80, 160 and 320 mg orally daily in the treatment of angina pectoris.
Odemuyiwa O; Peart I; Alberts C; Hall RJ
Br J Clin Pract; 1990 Jan; 44(1):9-12. PubMed ID: 2317442
[TBL] [Abstract][Full Text] [Related]
35. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
Floras JS; Jones JV; Hassan MO; Sleight P
Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
[TBL] [Abstract][Full Text] [Related]
36. Combination propranolol and bepridil therapy in stable angina pectoris.
Frishman WH; Charlap S; Farnham DJ; Sawin HS; Michelson EL; Crawford MH; DiBianco R; Kostis JB; Zellner SR; Michie DD
Am J Cardiol; 1985 Mar; 55(7):43C-49C. PubMed ID: 3883741
[TBL] [Abstract][Full Text] [Related]
37. Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol.
Jackson G; Harry JD; Robinson C; Kitson D; Jewitt DE
Br Heart J; 1978 Sep; 40(9):998-1004. PubMed ID: 101223
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of beta adrenergic blockade in coronary heart disease: propranolol in angina pectoris.
Miller RR; Olson HG; Pratt CM; Amsterdam EZ; Mason DT
Clin Pharmacol Ther; 1975 Nov; 18(5 Pt 1):598-605. PubMed ID: 810295
[TBL] [Abstract][Full Text] [Related]
39. Propranolol in angina pectoris: duration of improved exercise tolerance and circulatory effects after acute oral administration.
Thadani U; Parker JO
Am J Cardiol; 1979 Jul; 44(1):118-25. PubMed ID: 377932
[TBL] [Abstract][Full Text] [Related]
40. Diltiazem and propranolol combination for the treatment of chronic stable angina pectoris.
O'Hara MJ; Khurmi NS; Bowles MJ; Raftery EB
Clin Cardiol; 1987 Feb; 10(2):115-23. PubMed ID: 3545577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
